Tumor lysis syndrome risk factors
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2] Nazia Fuad M.D.
Overview
The most potent risk factor in the development of tumor lysis syndrome after initiating chemotherapy is kidney disease. Other risk factors include dehydration, hematologic tumors, and solid tumors.
Risk Factors
The followings are risk factors for developing tumor lysis syndrome after initiating chemotherapy:[1]
Common Risk Factors
- Common risk factors in the development of tumor lysis syndrome include:[2]
Less Common Risk Factors
- Less common risk factors in the development of TLS include:[2]
References
- ↑ “www.asn-online.org” (PDF).
- ↑ 2.0 2.1 Mirrakhimov AE, Voore P, Khan M, Ali AM (May 2015). “Tumor lysis syndrome: A clinical review”. World J Crit Care Med. 4 (2): 130–8. doi:10.5492/wjccm.v4.i2.130. PMC 4411564. PMID 25938028.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH